Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
58.7M
-
Shares change
-
-5.37M
-
Total reported value, excl. options
-
$266M
-
Value change
-
-$42.3M
-
Put/Call ratio
-
1.39
-
Number of buys
-
66
-
Number of sells
-
-72
-
Price
-
$4.52
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q1 2021
180 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q1 2021.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.7M shares
of 374M outstanding shares and own 15.68% of the company stock.
Largest 10 shareholders include Indaba Capital Management, L.P. (7.45M shares), BlackRock Inc. (6.25M shares), PRIMECAP MANAGEMENT CO/CA/ (5.42M shares), ORBIMED ADVISORS LLC (4.6M shares), Neuberger Berman Group LLC (4.38M shares), VANGUARD GROUP INC (3.74M shares), NEEDHAM INVESTMENT MANAGEMENT LLC (2.4M shares), STATE STREET CORP (1.27M shares), GEODE CAPITAL MANAGEMENT, LLC (1.27M shares), and Nuveen Asset Management, LLC (1.25M shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.